Status:
RECRUITING
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Lead Sponsor:
VA Office of Research and Development
Collaborating Sponsors:
Biomedical Advanced Research and Development Authority
Food and Drug Administration (FDA)
Conditions:
COVID-19, SARS-CoV-2 Infection
RSV
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during different periods of SARS-CoV-2 variant ...
Detailed Description
Objectives: This study will be completed in two phases. In the first phase, the investigators will establish a source population and comprehensively describe the temporal and geographic utilization o...
Eligibility Criteria
Inclusion
- Phase 1:
- \- Veterans aged 18 years with a laboratory-confirmed positive test for SARS-CoV-2 or a diagnosis of COVID-19 documented at any time since the beginning of the pandemic in January 2020 to present.
- Phase 2:
- All Veterans aged 18 years alive and in VHA care as of January 2018.
- Specific exclusion/inclusion criteria and observation periods will be further defined for each sub-study (See outcomes/publications).
Exclusion
- VA employees who are not enrollees
Key Trial Info
Start Date :
September 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
400000 Patients enrolled
Trial Details
Trial ID
NCT06160128
Start Date
September 26 2022
End Date
September 30 2027
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Portland Health Care System, Portland, OR
Portland, Oregon, United States, 97207-2964